Dan Baker, M.D. joined the Janssen Pharmaceutical Companies of Johnson & Johnson through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining Janssen, he has held participation and leadership roles in the clinical development of the industry-leading Janssen immunology portfolio for a plethora of indications, as well as other earlier development assets. As Disease Area Stronghold Leader for Rheumatoid Arthritis (RA), Dan is responsible for leading a cross-functional team of experts to outline near- and long-term, prioritized scientific and business strategies with the goal of maintaining industry leadership in RA.